Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
CALL
Canadian National Railway
CNI
$76.2B
| $2.82M | ﹤0.01% |
+23,300
| New | +$2.76M |
|
3127
CALL
Martin Marietta Materials
MLM
$37.7B
| $2.82M | ﹤0.01% |
6,100
+500
| +9% | +$197K |
|
3128
PUT
Commercial Metals
CMC
$7.48B
| $2.81M | ﹤0.01% |
+53,300
| New | +$2.49M |
|
|
CMRX
3129
DELISTED
Chimerix, Inc.
CMRX
| $2.79M | ﹤0.01% |
2,308,042
+1,260,884
| +120% | +$1.6M |
|
3130
Abeona Therapeutics
ABEO
$339M
| $2.79M | ﹤0.01% |
692,971
+515,016
| +289% | +$1.8M |
|
3131
Alta Equipment Group
ALTG
$192M
| $2.79M | ﹤0.01% |
160,900
+123,160
| +326% | +$1.82M |
|
3132
WSFS Financial
WSFS
$4B
| $2.79M | ﹤0.01% |
73,894
-255,212
| -78% | -$9.07M |
|
3133
United Rentals
URI
$64.1B
| $2.79M | ﹤0.01% |
6,255
-1,009
| -14% | -$374K |
|
3134
CALL
Fidelity National Information Services
FIS
$21.4B
| $2.78M | ﹤0.01% |
50,800
+44,000
| +647% | +$2.42M |
|
3135
NetEase
NTES
$78.6B
| $2.78M | ﹤0.01% |
28,724
-88,176
| -75% | -$7.96M |
|
3136
Wave Life Sciences
WVE
$993M
| $2.77M | ﹤0.01% |
761,389
-667,102
| -47% | -$2.69M |
|
3137
CALL
Chemours
CC
$2.35B
| $2.77M | ﹤0.01% |
75,000
| – | – |
|
3138
Fresenius Medical Care
FMS
$12.3B
| $2.77M | ﹤0.01% |
115,552
+12,500
| +12% | +$287K |
|
3139
Winmark
WINA
$1.21B
| $2.76M | ﹤0.01% |
8,301
+7,606
| +1,094% | +$2.58M |
|
3140
Maravai LifeSciences
MRVI
$1.14B
| $2.75M | ﹤0.01% |
221,413
+211,020
| +2,030% | +$2.85M |
|
3141
Kanzhun
BZ
$7.95B
| $2.75M | ﹤0.01% |
182,555
-584,009
| -76% | -$9.77M |
|
|
CMBM
3142
DELISTED
Cambium Networks
CMBM
| $2.74M | ﹤0.01% |
179,922
-160,460
| -47% | -$2.49M |
|
3143
Hecla Mining
HL
$13.7B
| $2.74M | ﹤0.01% |
531,674
+440,019
| +480% | +$2.51M |
|
3144
Standex International
SXI
$3.62B
| $2.74M | ﹤0.01% |
19,348
+11,643
| +151% | +$1.54M |
|
|
KNTE
3145
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.73M | ﹤0.01% |
+902,242
| New | +$3.48M |
|
3146
ProFrac Holding
ACDC
$909M
| $2.73M | ﹤0.01% |
+244,612
| New | +$2.9M |
|
3147
Forrester Research
FORR
$236M
| $2.73M | ﹤0.01% |
93,730
+60,475
| +182% | +$1.8M |
|
3148
CALL
Exelon
EXC
$45.3B
| $2.73M | ﹤0.01% |
66,900
-91,900
| -58% | -$3.8M |
|
|
PRLH
3149
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
| $2.72M | ﹤0.01% |
260,702
| – | – |
|
3150
PUT
Cooper Companies
COO
$13.9B
| $2.72M | ﹤0.01% |
28,400
+16,400
| +137% | +$1.54M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.